Verapamil Hydrochloride Tablet
Product Images NDC 68788-8696

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 68788-8696). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Verapamil HCl Extended-release Tablets Usp 120mg (120mg 100tabs)

Verapamil HCl Extended-release Tablets Usp 120mg (120mg 100tabs)
This is a description for Verapamil HCI Extended-Release Tablets, USP 120mg. It is a generic version of Calan SR and each film-coated tablet contains 120mg of verapamil hydrochloride. The packaging size and expiration date are not available. The tablets should be stored at room temperature. They are oval and blue in color, with the imprint "V12." The tablets are manufactured by Cadila Pharmaceuticals Limited. A caution notice mentions that the drug should not be transferred to anyone other than the prescribed patient. It is important to keep this medication out of the reach of children. Additional details include pharmaceutical company information and instructions in Spanish.*
FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
This text provides a chemical structure and molecular weight information of a compound named "Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino] propyl]-3,4-dimethoxy-a-(1-methylethyl) hydrochloride." The molecular formula is C27H38N204 - HCI with a molecular weight of 491.08 g/mol.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.